Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.1B | 18.3B | 16.6B | 15.0B |
Cost of revenue | 14.1B | 14.8B | 15.1B | 16.5B |
Gross profit | 5.0B | 3.5B | 1.5B | -1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.4B | 1.4B | 1.5B | 2.2B |
Other operating expenses | 4.4B | 4.3B | 4.0B | 4.2B |
Operating income | -2.4B | -3.9B | -5.8B | -9.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 45M | 43M | 34M | 42M |
Other income expense | — | — | — | — |
Pretax income | -5.4B | -2.0B | 9.4B | -8.4B |
Tax provision | 26M | 50M | 89M | 15M |
Net income | -5.4B | -2.1B | 9.3B | -8.4B |
Basic EPS | — | -3.3 | 14.6 | -13 |
Diluted EPS | — | -3.3 | 14.3 | -13 |
Basic average shares | — | 637.0M | 636.3M | 645.3M |
Diluted average shares | — | 637.0M | 649.6M | 645.3M |
EBITDA | 1.3B | -339M | -2.2B | -6.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 48M | 2M | -17M | 12M |
Preferred stock dividends | 0 | 0 | 0 | 0 |